4/A//SEC Filing
Gibbs Michael Terrence 4/A
Accession 0000899243-23-010680
CIK 0001492674other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 2:30 PM ET
Size
7.3 KB
Accession
0000899243-23-010680
Insider Transaction Report
Form 4/AAmended
Gibbs Michael Terrence
General Counsel
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-03-24−334→ 0 total→ Common Stock (334 underlying) - Exercise/Conversion
Common Stock
2023-03-24+334→ 6,851 total
Footnotes (3)
- [F1]The Form 4, as originally filed, incorrectly reported the amount of shares acquired as a result of the vesting of the Restricted Stock Units as 333.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]On March 24, 2020 the reporting person was granted 1,000 RSU's that vest in three equal annual installments commencing on March 24, 2021
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001665000
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 2:30 PM ET
- Size
- 7.3 KB